Litcius/Paper detail

Topical Clascoterone: The First Novel Agent for Acne Vulgaris in 40 Years

Chris Piszczatoski, Jason Powell

2021Clinical Therapeutics16 citationsDOI

Topics & Concepts

MedicineAcneIsotretinoinClinical trialAdverse effectFood and drug administrationRandomized controlled trialMEDLINEDrugDermatologyPharmacologyInternal medicineLawPolitical scienceAcne and Rosacea Treatments and EffectsDermatologic Treatments and Researchmelanin and skin pigmentation
Topical Clascoterone: The First Novel Agent for Acne Vulgaris in 40 Years | Litcius